Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¹è¾çµÈ »ç¶÷ Á¶°ñ¼¼Æ÷ ºÐÈ­¿¡ »çÀÌŬ·Î½ºÆ÷¸° A°¡ ¹ÌÄ¡´Â ¿µÇâ

The Effect of Cyclosporin A on Differentiation of Cultured Normal Human Osteoblast

´ëÇѱ¸°­¾Ç¾È¸éº´¸®ÇÐȸÁö 2011³â 35±Ç 1È£ p.13 ~ 18
ÀÌÁ¾Çå,
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌÁ¾Çå ( Lee Chong-Heon ) - ´Ü±¹´ëÇб³ Ä¡°ú´ëÇÐ ±¸°­º´¸®Çб³½Ç

Abstract


Cyclosporin A(CsA) as immunosuppressive drug is used to prevent immune reactions after organ transplant. And also It is reported that the effect of CsA on osteoblast differentiation has been controversial according to dosage. The purpose of this study was to examine the effect of various CsA concentrations on osteoblast differentiation. According to different concentration o f CsA, growth curve, apoptosis index MTT assay, ALP activation and osteocalcin secretion, in cultured NHost were analyzed. Treating osteoblasts with low concentrations of CsA increased growth rate, MTT assay activity, ALP activation and osteocalcin protein levels in a dose-dependent manner, while high concentration showed opposite results. Therefore, these results showed that low concentrations of CsA increased osteoblast differentiation, while high concentrations elicited an opposite response, showing inhibition of CsA on osteoblast differentiation. It suggested that different CsA concentrations might play in regulating NHost differentiation, and its specific activation of lower concentration will represent a viable anabolic therapy for bone resorption disease in future.

Å°¿öµå

Cyclosporin A; Differentiation; NHost

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI